Agenus reported $251.43M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US USD 251.43M 37.5M
Amgen AMGN:US USD 24.06B 4.74B
AstraZeneca AZN:LN USD 20.22B 693M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Celldex Therapeutics CLDX:US USD 334.6M 33.38M
Eli Lilly And LLY:US USD 17.64B 524.7M
Gilead Sciences GILD:US USD 13.55B 379M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Glaxosmithkline GSK:US GBP 20.25B 33.94B
Immunogen IMGN:US USD 330.42M 63.51M
Intrexon XON:US USD 162.81M 1.81M
Jiangsu Hengrui Me. 600276:CH CNY 29.62B 1.29B
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Macrogenics MGNX:US USD 147.81M 19.82M
Merck MRK:GR EUR 12.94B 527M
Merk MRK:US USD 33.56B 1.44B
Northwest Biotherapeutics NWBO:US USD 11.76M 4.59M
Novartis NOVN:VX USD 36.95B 1.19B
Novavax NVAX:US USD 1.76B 376.04M
Pfizer PFE:US USD 70.4B 2.94B
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Rigel Pharmaceuticals RIGL:US USD 110.44M 10.08M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Veracyte VCYT:US USD 238.52M 3.47M
YTE INCY:US USD 3.82B 195.27M